Results 151 to 160 of about 13,097 (191)

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab. [PDF]

Drugs Real World Outcomes
Blitz-Shabbir K, Banks AM, Garg H, Nelson F, Shah S, Belviso N, Mendoza JP, Avila RL, Bian B, Fong K.   +9 more
europepmc   +1 more source

Association between dietary carbohydrate intake and multiple sclerosis risk: a large-scale cohort study. [PDF]

Front Nutr
Yuan Q, Wang M, Chen S, Lin H, Yang Y, Zhao S, Hua B, Guo J, Sun X, Ye D, Li J, Mao Y.   +11 more
europepmc   +1 more source

In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs. [PDF]

Biochem Biophys Rep
Kizhakkiniyakath SA, Choudhury T, Rajan MV, Rathee S, Meena B, Hariprasad G.   +5 more
europepmc   +1 more source

Shifts in treatment initiation patterns among newly diagnosed multiple sclerosis patients in Germany: a claims data analysis from 2017 to 2022. [PDF]

Ther Adv Neurol Disord
Stratil AS, Papukchieva S, Joschko N, Meuth SG, Friedrich B.   +4 more
europepmc   +1 more source

Structure-based investigation of a DNA aptamer targeting PTK7 reveals an intricate 3D fold guiding functional optimization. [PDF]

Proc Natl Acad Sci U S A
He A, Wan L, Zhang Y, Yan Z, Guo P, Han D, Tan W.   +6 more
europepmc   +1 more source

Dynamic and calving response of a major Greenland ice stream to a propagating subglacial flood

Wehrlé A, Lüthi M, Kneib-Walter A, Nap A, Rousseau H, Jouvet G, Walter F.   +6 more
europepmc   +1 more source